A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA)

Autor: Ayres BD, Bloomenstein MR, Loh J, Chester T, Saenz B, Echegoyen J, Kannarr SR, Perez VL, Rodriguez TC, Dickerson Jr JE

Publikováno v: Clinical Ophthalmology, Vol Volume 17, Pp 3925-3940 (2023)

Brandon D Ayres,1 Marc R Bloomenstein,2 Jennifer Loh,3 Thomas Chester,4 Bobby Saenz,5,6 Julio Echegoyen,7 Shane R Kannarr,8 Victor L Perez,9 Tomasita C Rodriguez,10 Jaime E Dickerson Jr10,11 1Private Practice, Philadelphia, PA, USA; 2Schwartz Laser E

Externí odkaz: https://doaj.org/article/13687a4c86734ca8810ec1749234da07

Improved Signs and Symptoms of Dry Eye Disease for Restasis ^® Patients Following a Single Tearcare ^® Treatment: Phase 2 of the SAHARA Study.

Autor: Ayres BD; Private Practice, Philadelphia, PA, USA., Bloomenstein MR; Schwartz Laser Eye Center, Scottsdale, AZ, USA., Loh J; Loh Ophthalmology Associates, Miami, FL, USA., Chester T; Cleveland Eye Clinic, Brecksville, OH, USA., Saenz B; Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX, USA.; LASIK San Antonio, Kerrville, TX, USA., Echegoyen J; Gordon Schanzlin New Vision Institute, La Jolla, CA, USA., Kannarr SR; Kannarr Eye Care, Pittsburg, KS, USA., Rodriguez TC; Sight Sciences, Menlo Park, CA, USA., Dickerson JE Jr; Sight Sciences, Menlo Park, CA, USA.; North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2024 May 28; Vol. 18, pp. 1525-1534. Date of Electronic Publication: 2024 May 28 (Print Publication: 2024).

A Randomized, Controlled Trial Comparing Tearcare ^® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA).

Autor: Ayres BD; Private Practice, Philadelphia, PA, USA., Bloomenstein MR; Schwartz Laser Eye Center, Scottsdale, AZ, USA., Loh J; Loh Ophthalmology Associates, Miami, FL, USA., Chester T; Cleveland Eye Clinic, Brecksville, OH, USA., Saenz B; Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX, USA.; LASIK San Antonio, Kerrville, TX, USA., Echegoyen J; Gordon Schanzlin New Vision Institute, La Jolla, CA, USA., Kannarr SR; Kannarr Eye Care, Pittsburg, KS, USA., Perez VL; Department of Ophthalmology, Duke University Medical Center, Durham, NC, USA., Rodriguez TC; Sight Sciences, Menlo Park, CA, USA., Dickerson JE Jr; Sight Sciences, Menlo Park, CA, USA.; North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2023 Dec 18; Vol. 17, pp. 3925-3940. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2023).

CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease.

Autor: Tsagkaraki E; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.; University of Crete School of Medicine, Crete, 71003, Greece., Nicoloro SM; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., DeSouza T; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Solivan-Rivera J; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Desai A; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Lifshitz LM; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Shen Y; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Kelly M; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Guilherme A; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Henriques F; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Amrani N; University of Crete School of Medicine, Crete, 71003, Greece., Ibraheim R; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Rodriguez TC; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Luk K; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Maitland S; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Friedline RH; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Tauer L; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Hu X; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Kim JK; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Wolfe SA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.; Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Sontheimer EJ; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA.; Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, MA, 01605, USA., Corvera S; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA. Silvia.Corvera@umassmed.edu., Czech MP; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA. Michael.Czech@umassmed.edu.

Publikováno v: Nature communications [Nat Commun] 2021 Nov 26; Vol. 12 (1), pp. 6931. Date of Electronic Publication: 2021 Nov 26.